Assort Health Raises $120 Million for Healthcare AI Agents

The money pouring into AI agents keeps finding its way to unglamorous corners of the economy, and few are less glamorous than the medical front desk. On June 24, Assort Health said it had raised a $120 million Series C led by Menlo Ventures, valuing the company at $1.2 billion and pushing its total funding past $222 million.

What Assort sells is narrow and specific: AI agents that run the patient journey for clinics and hospital systems. The software answers calls and handles scheduling, intake, referrals, forms, medication refills, and payments, the repetitive administrative work that ties up staff and leaves patients on hold. The company says its models are trained on 190 million specialty patient interactions and update in real time, which it argues a general-purpose chatbot cannot match in a field this tangled with insurance rules and clinical detail.

The numbers behind the round

Assort says revenue has grown twentyfold over the past 15 months. It reports that customers see a 5 percent lift in appointment volume, more than double the labor capacity on patient-access teams, and a patient satisfaction score of 4.3 out of 5. Those are the company's own figures rather than audited results, the usual caveat for a private startup raising money, but the growth rate helps explain why investors lined up.

And line up they did. Beyond Menlo, the round drew Lightspeed Venture Partners, Felicis, First Round Capital, Chemistry, Tau Ventures, Quiet Capital, and, in a more unusual entry, the former NFL quarterback Joe Montana through his venture firm, according to FinSMEs and HIT Consultant.

Why healthcare, why now

Healthcare has become one of the more active proving grounds for AI that does real work rather than just answering questions. The appeal is straightforward. Administrative overhead is enormous, staffing is chronically short, and much of the work is rule-bound and phone-based, which is exactly the shape of problem current agents handle well. The risk is just as clear, because a mistake in scheduling, billing, or a refill lands on a real patient.

Assort's bet is that a system built only for healthcare, rather than a general assistant pointed at it, is the safer way to automate that work. It is a claim worth watching as more of the patient experience, the part most people never think about until they are stuck in a phone tree, gets handed to software. The same week brought a reminder of the upside, as researchers continued to report AI systems helping doctors crack rare disease cases that had gone unsolved for years.